NRIX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $22.99

Market Cap (MRQ) $2.38B

P/E (TTM) -6.6

EPS (TTM) $-3.46

Revenue (TTM) $37M

ROE (TTM) -80.3%

52W Range $9–$28

NRIX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Nurix Therapeutics, Inc. - Common stock Company overview from Wikipedia

05 · wikidata

Wikidata ↗

sectorHealthcare industryBiotechnology employees317 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$84M

2019-11-30 → 2025-11-30

EPS$-3.05

2021-11-30 → 2025-11-30

Free Cash Flow$-263M

2020-11-30 → 2025-11-30

Net margin-928.4%

2020-11-30 → 2025-11-30

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	NRIX	5Y avg	Peer Median	Verdict
P/E (TTM)	-6.65Y avg ≈-5.9	≈-5.9	·	·
P/S (TTM)	64.85Y avg ≈22.9	≈22.9	50.1	Fair value
P/B (MRQ)	5.95Y avg ≈2.7	≈2.7	4.5	Fair value
Price / FCF	-8.95Y avg ≈-7.4	≈-7.4	·	·
Price / Cash Flow	-9.45Y avg ≈-7.9	≈-7.9	·	·
Price / Tangible Book	4.35Y avg ≈2.7	≈2.7	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	NRIX	5Y avg	Peer Median	Verdict
Operating Margin (TTM)	-982.4%5Y avg ≈-360.9%	≈-360.9%	-7718.9%	Top tier
EBITDA Margin	-340.2%5Y avg ≈-360.9%	≈-360.9%	-7701.1%	Top tier
Pretax Margin	-314.0%5Y avg ≈-343.2%	≈-343.2%	-525.2%	Weak
Net Profit Margin (TTM)	-928.4%5Y avg ≈-343.5%	≈-343.5%	-7584.4%	Top tier
ROA (TTM)	-60.6%5Y avg ≈-36.2%	≈-36.2%	-37.6%	Weak
ROE (TTM)	-80.3%5Y avg ≈-50.2%	≈-50.2%	-43.8%	Weak
ROIC	-53.2%5Y avg ≈-47.2%	≈-47.2%	-39.9%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	NRIX	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		6.35Y avg ≈5.2	≈5.2	14.6	Low liquidity
Quick Ratio		2.95Y avg ≈2.7	≈2.7	10.3	Low liquidity

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	NRIX	5Y avg	Peer Median	Verdict
Revenue YoY	53.9%5Y avg ≈44.2%	≈44.2%	·	·
Revenue CAGR 3Y	29.5%5Y avg ≈38.3%	≈38.3%	·	·
Revenue CAGR 5Y	36.4%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	NRIX	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-3.055Y avg ≈$-3.00	≈$-3.00	·	·
Revenue / Share	$0.975Y avg ≈$1.00	≈$1.00	·	·
Cash Flow / Share	$-2.885Y avg ≈$-2.56	≈$-2.56	·	·
Cash / Share	$2.435Y avg ≈$1.63	≈$1.63	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	5Y trend	NRIX	5Y avg	Peer Median	Verdict
Asset Turnover		0.15Y avg ≈0.1	≈0.1	0.1	Top tier
Revenue / Employee		≈$264.9K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 3.0%

Next Report Oct 07, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Jul 7, 2026	$-0.81	$-0.73	-10.8%
March 31, 2026		$-0.79	$-0.77	-2.7%
Dec. 31, 2025		$-0.82	$-0.89	7.7%
Sept. 30, 2025		$-1.03	$-0.86	-20.0%
June 30, 2025		$-0.52	$-0.74	30.1%
March 31, 2025		$-0.67	$-0.78	14.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 13

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$84M	$55M	$77M	$39M	$30M	$18M	$31M
R&D Expense	$317M	$222M	$189M	$184M	$116M	$66M	$45M
SG&A Expense	$53M	$46M	$43M	$38M	$31M	$16M	$8M
Operating Expenses	$370M	$268M	$232M	$222M	$148M	$83M	$53M
Operating Income	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	$-22M
Pretax Income	$-264M	$-193M	$-144M	$-180M	$-117M	$-64M	$-21M
Income Tax	$760.0K	$270.0K	$0	$0	$131.0K	$-21M	$239.0K
Net Income	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	$-22M
EPS (Basic)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
EPS (Diluted)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
Shares (Basic)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
Shares (Diluted)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
EBITDA	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	·

Balance Sheet 21

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$247M	$110M	$55M	$64M	$81M	$119M	$35M
Short-term Investments	·	·	·	$245M	$215M	$162M	$3M
Receivables	·	$0	·	$0	$6M	·	·
Prepaid Expense	$14M	$10M	$8M	$9M	$9M	$6M	$2M
Current Assets	$607M	$619M	$296M	$318M	$311M	$298M	$39M
PP&E (Net)	$22M	$18M	$17M	$17M	$11M	$7M	$4M
PP&E (Gross)	$60M	$52M	$43M	$37M	$26M	$20M	$15M
Accum. Depreciation	$38M	$35M	$26M	$20M	$15M	$13M	$11M
Other Non-current Assets	$7M	$3M	$4M	$4M	$3M	$177.0K	$147.0K
Total Assets	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Accounts Payable	$11M	$11M	$6M	$5M	$7M	$3M	$2M
Current Liabilities	$86M	$96M	$87M	$71M	$66M	$45M	$16M
Capital Leases	$53M	$20M	$23M	$6M	$9M	·	·
Other Non-current Liabilities	·	·	·	·	·	$850.0K	$2M
Total Liabilities	$149M	$142M	$155M	$113M	$134M	$106M	$54M
Common Stock	$102.0K	$76.0K	$49.0K	$47.0K	$45.0K	$39.0K	$4.0K
Retained Earnings	$-1.00B	$-739M	$-545M	$-401M	$-221M	$-104M	$-60M
AOCI	$105.0K	$150.0K	$-655.0K	$-4M	$-608.0K	$87.0K	$-2.0K
Stockholders' Equity	$539M	$527M	$200M	$304M	$342M	$290M	$-58M
Liabilities + Equity	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Shares Outstanding	101,807,484	75,870,718	48,718,552	47,172,299	44,664,371	38,864,872	3,595,334

Cash Flow 11

Metric	2025	2024	2023	2022	2021	2020	2019
D&A	$9M	$9M	$8M	$5M	$3M	$2M	$2M
Stock-based Comp	$38M	$34M	$34M	$28M	$16M	$4M	$510.0K
Operating Cash Flow	$-249M	$-173M	$-81M	$-160M	$-84M	$-80.0K	$601.0K
CapEx	$14M	$9M	$8M	$12M	$6M	$5M	$2M
Investing Cash Flow	$148M	$-258M	$68M	$27M	$-108M	$-254M	$8M
Stock Issued	$0	$290M	$0	$19M	$150M	$218M	·
Net Stock Activity	$0	$290M	$0	$19M	$150M	$218M	·
Financing Cash Flow	$239M	$486M	$3M	$117M	$154M	$339M	$126.0K
Net Change in Cash	$137M	$55M	$-10M	$-15M	$-39M	$85M	$9M
Taxes Paid	·	·	·	·	·	$1.0K	$1.0K
Free Cash Flow	$-263M	$-182M	$-90M	$-172M	$-90M	$-5M	·

Profitability 7

Metric	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
Net Margin	-314.9%	-354.9%	-187.0%	-466.9%	-393.9%	-242.7%	·
Pretax Margin	-314.0%	-354.4%	-187.0%	-466.9%	-393.5%	-357.9%	·
EBITDA Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
ROA	-39.0%	-37.8%	-37.3%	-40.4%	-26.9%	-19.6%	·
ROE	-53.6%	-42.8%	-66.3%	-55.8%	-32.7%	-14.5%	·
ROIC	-53.2%	-40.5%	·	-60.5%	-34.5%	-15.2%	·

Liquidity & Solvency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.0	6.5	3.4	4.5	4.7	6.7	·
Quick Ratio		2.9	1.1	0.6	4.4	4.6	6.3	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.1	0.1	0.2	0.1	0.1	0.1	·
Receivables Turnover		·	·	·	12.9	9.9	·	·

Per Share 6

Metric	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$5.29	$6.95	$4.12	$6.44	$7.66	$7.47	·
Revenue / Share	$0.97	$0.81	$1.42	$0.79	·	·	·
Cash Flow / Share	$-2.88	$-2.57	$-1.50	$-3.29	·	·	·
Cash / Share	$2.43	$1.45	$1.12	$1.37	$1.80	$3.07	·
Dividend / Share	$0.00	$0.00	·	·	·	$0.00	$0.00
EPS (TTM)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	53.9%	-29.1%	99.3%	29.8%	67.0%	·	·
Revenue CAGR 3Y	29.5%	22.4%	62.9%	·	·	·	·
Revenue CAGR 5Y	36.4%	·	·	·	·	·	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$84M	$55M	$77M	$39M	$30M	$18M	·
Net Income TTM	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	·
Market Cap	$1.80B	$1.68B	$303M	$584M	$1.29B	$1.66B	·
P/E	-5.8	-7.7	-2.3	-3.3	-10.6	·	·
P/S	21.4	30.8	3.9	15.1	43.3	93.0	·
P/B	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Tangible Book	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Cash Flow	-7.2	-9.7	-3.7	-3.7	-15.3	-20705.3	·
P / FCF	-6.8	-9.2	-3.4	-3.4	-14.3	-357.5	·
Earnings Yield	-17.2%	-13.0%	-42.6%	-29.9%	-9.5%	·	·

Income Statement 13

Metric	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$9M	$6M	$14M	$8M	$44M	$18M	$13M	$13M	$12M	$17M	$15M	$18M	$31M	$13M	$7M	$11M
R&D Expense	$88M	$84M	$83M	$86M	$78M	$70M	$67M	$55M	$49M	$50M	$50M	$48M	$46M	$46M	$46M	$48M
SG&A Expense	$16M	$15M	$14M	$13M	$14M	$12M	$11M	$12M	$12M	$12M	$11M	$11M	$12M	$10M	$9M	$10M
Operating Expenses	$103M	$99M	$97M	$99M	$92M	$81M	$78M	$67M	$61M	$62M	$60M	$58M	$57M	$56M	$55M	$58M
Operating Income	$-94M	$-92M	$-83M	$-91M	$-48M	$-63M	$-65M	$-55M	$-49M	$-45M	$-45M	$-40M	$-27M	$-43M	$-49M	$-47M
Pretax Income	$-90M	·	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-44M	$-41M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
Income Tax	$-271.0K	$0	$0	$0	$760.0K	$0	$8.0K	$82.0K	$90.0K	$90.0K	$0	$0	$0	$0	$0	$0
Net Income	$-90M	$-87M	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-45M	$-42M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
EPS (Basic)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
EPS (Diluted)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
Shares (Basic)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
Shares (Diluted)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
EBITDA	$-94M	$-92M	·	$-91M	$-48M	$-63M	·	$-55M	$-49M	$-45M	·	$-40M	$-27M	$-43M	·	$-47M

Balance Sheet 20

Metric	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$68M	$71M	$247M	$78M	$84M	$76M	$110M	$99M	$117M	$50M	$55M	$42M	$59M	$34M	$64M	$48M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	$217M	$222M	$244M	·	$297M
Receivables	·	·	·	·	$19M	·	·	·	·	·	·	$2M	·	·	·	·
Prepaid Expense	$13M	$14M	$14M	$12M	$11M	$14M	$10M	$8M	$7M	$7M	·	$7M	$9M	$11M	·	$10M
Current Assets	$456M	$554M	$607M	$441M	$515M	$564M	$619M	$456M	$450M	$251M	·	$268M	$290M	$288M	·	$355M
PP&E (Net)	$20M	$22M	$22M	$20M	$19M	$18M	$18M	$17M	$19M	$18M	·	$17M	$18M	$18M	·	$17M
PP&E (Gross)	$61M	$61M	$60M	$61M	$57M	$55M	$52M	$49M	$48M	$46M	·	$42M	$42M	$39M	·	$35M
Accum. Depreciation	$41M	$40M	$38M	$41M	$39M	$37M	$35M	$32M	$30M	$28M	·	$25M	$23M	$21M	·	$18M
Other Non-current Assets	$8M	$7M	$7M	$7M	$6M	$6M	$3M	$3M	$3M	$3M	·	$4M	$4M	$4M	·	$4M
Total Assets	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Accounts Payable	$12M	$10M	$11M	$9M	$6M	$8M	$11M	$4M	$3M	$6M	·	$2M	$5M	$6M	·	$6M
Current Liabilities	$72M	$92M	$86M	$82M	$76M	$90M	$96M	$86M	$81M	$88M	·	$61M	$72M	$65M	·	$68M
Capital Leases	$55M	$55M	$53M	$53M	$47M	$20M	$20M	$21M	$21M	$22M	·	$3M	$4M	$5M	·	$8M
Total Liabilities	$133M	$155M	$149M	$150M	$144M	$134M	$142M	$137M	$140M	$144M	·	$74M	$91M	$96M	·	$117M
Common Stock	$104.0K	$103.0K	$102.0K	$77.0K	$76.0K	$76.0K	$76.0K	$67.0K	$64.0K	$49.0K	·	$49.0K	$48.0K	$47.0K	·	$47.0K
Retained Earnings	$-1.18B	$-1.09B	$-1.00B	$-925M	$-839M	$-795M	$-739M	$-680M	$-631M	$-587M	·	$-503M	$-466M	$-442M	·	$-355M
AOCI	$-145.0K	$56.0K	$105.0K	$119.0K	$-20.0K	$226.0K	$150.0K	$344.0K	$-135.0K	$-350.0K	·	$-1M	$-2M	$-3M	·	$-4M
Stockholders' Equity	$403M	$481M	$539M	$372M	$448M	$481M	$527M	$377M	$371M	$169M	$200M	$234M	$260M	$274M	$304M	$343M
Liabilities + Equity	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Shares Outstanding	103,701,511	103,399,813	101,807,484	76,872,686	76,433,664	76,234,799	75,870,718	67,083,523	64,356,535	49,136,954	·	48,503,768	47,631,208	47,444,853	·	47,147,781

Cash Flow 10

Metric	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	·	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Stock-based Comp	·	$9M	$9M	$10M	$10M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$9M	$8M	$8M	$7M
Operating Cash Flow	·	$-72M	$-68M	$-57M	$-63M	$-61M	$-49M	$-42M	$-40M	$-42M	$27M	$-41M	$-18M	$-48M	$-38M	$-46M
CapEx	·	$1M	$5M	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$3M	$2M	$1M	$2M	$3M	$3M
Investing Cash Flow	·	$-124M	$346.0K	$50M	$71M	$26M	$-141M	$-21M	$-131M	$36M	$-14M	$23M	$44M	$16M	$55M	$-63M
Stock Issued	·	$18M	$0	$0	·	$0	$199M	$42M	·	·	$0	$0	·	·	$0	·
Net Stock Activity	·	$18M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	·	$20M	$236M	$1M	$6.0K	$1M	$201M	$46M	$238M	$2M	$7.0K	$2M	$25.0K	$1M	$-135.0K	$115M
Net Change in Cash	·	$-176M	$169M	$-6M	$8M	$-34M	$11M	$-18M	$67M	$-5M	$12M	$-17M	$25M	$-31M	$17M	$6M
Free Cash Flow	·	$-73M	·	·	·	$-65M	·	·	·	$-45M	·	·	·	$-51M	·	·

Profitability 7

Metric	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
Net Margin	-990.1%	-1394.3%	·	-1094.8%	-98.7%	-305.4%	·	-388.9%	-368.4%	-250.3%	·	-200.3%	-79.1%	-321.1%	·	-423.6%
Pretax Margin	-993.1%	·	·	-1094.8%	-96.9%	-305.4%	·	-388.3%	-367.6%	-249.8%	·	·	·	·	·	-423.6%
EBITDA Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
ROA	-15.9%	·	·	-16.7%	-7.9%	-12.2%	·	-11.9%	-10.3%	-12.2%	·	-9.6%	-6.5%	-10.1%	·	-9.6%
ROE	-21.1%	·	·	-23.1%	-10.6%	-17.3%	·	-16.0%	-14.1%	-18.8%	·	-12.8%	-9.2%	-14.1%	·	-12.7%
ROIC	-23.3%	·	·	-24.6%	-11.0%	-13.1%	·	-14.5%	-13.1%	-26.9%	·	·	·	·	·	-13.6%

Liquidity & Solvency 2

Metric	Trend	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		6.3	·	·	5.4	6.8	6.3	·	5.3	5.6	2.9	·	4.4	4.0	4.4	·	5.3
Quick Ratio		0.9	·	·	1.0	1.4	0.8	·	1.1	1.4	0.6	·	4.2	3.9	4.3	·	5.1

Efficiency 2

Metric	Trend	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.1	0.0	·	0.0	0.0	0.0	·	0.0	0.1	0.0	·	0.0
Receivables Turnover		·	·	·	·	4.1	·	·	·	·	·	·	18.5	·	·	·	·

Per Share 6

Metric	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$3.88	·	·	$4.84	$5.86	$6.31	·	$5.62	$5.76	$3.43	·	$4.82	$5.46	$5.78	·	$7.27
Revenue / Share	$0.08	$0.06	·	$0.09	$0.53	$0.22	·	$0.17	$0.19	$0.30	·	$0.34	$0.57	$0.23	·	$0.21
Cash Flow / Share	·	$-0.65	·	·	·	$-0.73	·	·	·	$-0.76	·	·	·	$-0.90	·	·
Cash / Share	$0.65	·	·	$1.02	$1.10	$1.00	·	$1.48	$1.81	$1.01	·	$0.87	$1.24	$0.71	·	$1.01
Dividend / Share	·	$0.00	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
EPS (TTM)	$-3.46	$-3.17	·	·	·	·	·	$-2.91	$-2.92	$-2.66	·	$-2.73	$-2.95	$-3.51	·	$-3.71

Valuation (TTM) 9

Metric	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$37M	$77M	·	·	·	·	·	$56M	$62M	$81M	·	$69M	$61M	$42M	·	$39M
Net Income TTM	·	$-273M	·	·	·	·	·	$-177M	$-165M	$-145M	·	$-149M	$-157M	$-179M	·	$-171M
Market Cap	$1.84B	·	·	$718M	$812M	$1.18B	·	$1.69B	$1.01B	$607M	·	$412M	$482M	$447M	·	$742M
P/E	-5.1	-5.3	·	·	·	·	·	-8.7	-5.4	-4.6	·	-3.1	-3.4	-2.7	·	-4.2
P/S	50.1	·	·	·	·	·	·	30.0	16.3	7.5	·	6.0	7.9	10.7	·	18.9
P/B	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Tangible Book	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Cash Flow	·	·	·	·	·	-19.3	·	·	·	-14.5	·	·	·	-9.2	·	·
Earnings Yield	-19.5%	-18.9%	·	·	·	·	·	-11.6%	-18.5%	-21.5%	·	-32.1%	-29.1%	-37.2%	·	-23.6%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Revenue	$84M	$55M	$77M	$39M	$30M
Operating Margin %	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%
Net Income	$-264M	$-194M	$-144M	$-180M	$-117M
Diluted EPS	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73

Metric	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Current Ratio	7.0	6.5	3.4	4.5	4.7
Quick Ratio	2.9	1.1	0.6	4.4	4.6

Metric	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Free Cash Flow	$-263M	$-182M	$-90M	$-172M	$-90M

Institutional owners (13F) 223 filers · $2.8B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 223

Value held $2.8B

New positions 47

Exited positions 26

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
47 (+3 vs prior Q)	26 (0 vs prior Q)	67 (-2 vs prior Q)	63 (+20 vs prior Q)	-283K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
BlackRock, Inc.	$212,768,666	8,770,349	7.57%	Shares
Vestal Point Capital, LP	$195,293,000	8,050,000	6.95%	Shares
Deep Track Capital, LP	$187,686,398	7,736,455	6.68%	Shares
Rubric Capital Management LP	$175,345,894	7,227,778	6.24%	Shares
FMR LLC	$133,071,325	5,485,215	4.73%	Shares
MORGAN STANLEY	$115,537,879	4,762,484	4.11%	Shares
STATE STREET CORP	$113,469,939	4,677,244	4.04%	Shares
BAKER BROS. ADVISORS LP	$113,016,569	4,658,556	4.02%	Shares
VANGUARD GROUP INC	$112,862,243	5,949,512	4.01%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$109,061,534	4,495,529	3.88%	Shares
PERCEPTIVE ADVISORS LLC	$104,813,438	4,320,422	3.73%	Shares
Redmile Group, LLC	$98,830,073	4,073,787	3.51%	Shares
GENERAL ATLANTIC, L.P.	$73,560,808	3,032,185	2.62%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$61,566,526	2,537,291	2.19%	Shares
Pictet Asset Management Holding SA	$57,040,888	2,351,232	2.03%	Shares
ARK Investment Management LLC	$43,502,930	1,793,196	1.55%	Shares
Capital World Investors	$43,374,842	1,787,916	1.54%	Shares
Trails Edge Capital Partners, LP	$38,166,318	1,573,220	1.36%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$35,974,208	1,482,861	1.28%	Shares
CITADEL ADVISORS LLC	$35,832,481	1,477,019	1.27%	Shares
Soleus Capital Management, L.P.	$35,544,854	1,465,163	1.26%	Shares
DIMENSIONAL FUND ADVISORS LP	$34,720,069	1,431,317	1.23%	Shares
EVENTIDE ASSET MANAGEMENT, LLC	$31,486,884	1,297,893	1.12%	Shares
BRAIDWELL LP	$31,217,016	1,286,769	1.11%	Shares
Kynam Capital Management, LP	$28,984,805	1,194,757	1.03%	Shares
Woodline Partners LP	$25,812,786	1,064,006	0.92%	Shares
Sumitomo Mitsui Trust Group, Inc.	$23,858,788	983,462	0.85%	Shares
Amova Asset Management Americas, Inc.	$23,848,954	983,462	0.85%	Shares
Affinity Asset Advisors, LLC	$23,474,461	967,620	0.83%	Shares
UBS Group AG	$22,249,259	917,117	0.79%	Shares
NORTHERN TRUST CORP	$21,253,458	876,070	0.76%	Shares
BANK OF AMERICA CORP /DE/	$20,429,079	842,089	0.73%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$20,215,761	833,296	0.72%	Shares
Nuveen, LLC	$20,034,709	825,833	0.71%	Shares
GOLDMAN SACHS GROUP INC	$19,737,670	813,589	0.70%	Shares
KENNEDY CAPITAL MANAGEMENT LLC	$17,576,564	724,508	0.63%	Shares
VANGUARD FIDUCIARY TRUST CO	$16,650,560	686,338	0.59%	Shares
Rhenman & Partners Asset Management AB	$16,599,905	684,250	0.59%	Shares
RAYMOND JAMES FINANCIAL INC	$14,392,512	593,262	0.51%	Shares
Sofinnova Investments, Inc.	$12,714,617	524,098	0.45%	Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$11,575,441	477,141	0.41%	Shares
Elmind Capital, LP	$11,159,600	460,000	0.40%	Shares
CITIGROUP INC	$9,446,456	389,384	0.34%	Shares
Candriam S.C.A.	$9,159,082	377,902	0.33%	Shares
Fisher Asset Management, LLC	$8,963,219	369,465	0.32%	Shares
JACOBS LEVY EQUITY MANAGEMENT, INC	$8,821,009	363,603	0.31%	Shares
FIRST TRUST ADVISORS LP	$8,754,172	360,848	0.31%	Shares
BNP PARIBAS FINANCIAL MARKETS	$8,262,422	340,578	0.29%	Shares
WELLINGTON MANAGEMENT GROUP LLP	$8,106,188	334,138	0.29%	Shares
ArrowMark Colorado Holdings LLC	$7,636,126	314,762	0.27%	Shares

Show all 223 institutional owners →

Company insiders 20 insiders · 6 officers · 11 directors

19

Insider	Role	Last activity	Shares owned	Sells 12m	Net 12m
Arthur T Sands	President, CEO	Feb. 10, 2026 A	·	0	$0
Hans Van Houte	Chief Financial Officer	Aug. 4, 2026 S	40,166	10	$-635,401
Stefani Wolff	EVP and COO	April 30, 2023 M	6,113	0	$0
Christine Ring	Chief Legal Officer	Oct. 2, 2026 M	9,110	21	$-3,398,693
Gwenn Hansen	Chief Scientific Officer	Sept. 1, 2026 M	117,227	10	$-630,908
Pierre Beaurang	Chief Business Officer	Aug. 10, 2021 M	4,330	0	$0
Edward C Saltzman	Director	May 15, 2026 A	·	0	$0
Roger D Dansey	Director	May 15, 2026 A	·	0	$0
David L. Lacey	Director	May 15, 2026 A	·	0	$0
Anil Kapur	Director	May 15, 2026 A	·	0	$0
Roy D. Baynes	Director	May 15, 2026 A	·	0	$0
Paul M Silva	Director	May 15, 2026 A	·	0	$0
Lori Anne Kunkel	Director	May 19, 2025 A	0	0	$0
Clay B Siegall	Director	May 5, 2022 A	·	0	$0
Jeffrey K Tong	Director	May 6, 2021 A	·	0	$0
Robert Tjian	Director	July 28, 2020 C	124,999	0	$0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.	10% owner	July 28, 2020 C	784,313	0	$0
Judith A Reinsdorf	·	May 15, 2026 A	·	0	$0
Julia P Gregory	·	May 15, 2026 A	10,750	0	$0
Leon Chen	·	May 6, 2021 A	·	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 41 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
ARKG · ARK ETF Trust	2.51%	1,682,054 NS	July 31, 2026	N-PORT
PTH · Invesco Exchange-Traded Fund Trust	1.24%	153,433 SH	Oct. 2, 2026	Daily
BBC · ETFis Series Trust I	0.92%	18,337 NS	July 31, 2026	N-PORT
IWC · iShares Trust	0.59%	325,791 SH	Sept. 11, 2026	Daily
LABU · Direxion Shares ETF Trust	0.39%	83,566 NS	July 31, 2026	N-PORT
FYC · First Trust Exchange-Traded AlphaDE…	0.38%	212,938 NS	July 31, 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0.36%	62,236 SH	Oct. 2, 2026	Daily
IBB · iShares Trust	0.19%	749,550 SH	Sept. 11, 2026	Daily
IBBQ · Invesco Exchange-Traded Fund Trust …	0.16%	7,333 SH	Oct. 2, 2026	Daily
IWO · iShares Trust	0.13%	693,157 SH	Sept. 11, 2026	Daily
FYX · First Trust Exchange-Traded AlphaDE…	0.12%	71,916 NS	July 31, 2026	N-PORT
FFSM · FIDELITY COVINGTON TRUST	0.11%	71,221 NS	July 31, 2026	N-PORT
PWS · Pacer Funds Trust	0.11%	1,142 NS	July 31, 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0.11%	79,174 SH	Aug. 19, 2026	Daily
PRFZ · Invesco Exchange-Traded Fund Trust	0.09%	103,798 SH	Oct. 2, 2026	Daily
IWM · iShares Trust	0.08%	2,461,076 SH	Sept. 11, 2026	Daily
FAD · First Trust Exchange-Traded AlphaDE…	0.08%	19,290 NS	July 31, 2026	N-PORT
RSSL · Global X Funds	0.07%	45,904 NS	July 31, 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0.07%	551,605 SH	Aug. 19, 2026	Daily
OMFS · Invesco Exchange-Traded Self-Indexe…	0.06%	6,461 SH	Oct. 2, 2026	Daily
DFAS · Dimensional ETF Trust	0.05%	313,021 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.03%	1,114,166 SH	Aug. 19, 2026	Daily
VTWV · VANGUARD SCOTTSDALE FUNDS	0.03%	19,327 SH	Aug. 19, 2026	Daily
ISCG · iShares Trust	0.03%	9,673 SH	Sept. 11, 2026	Daily
FHLC · FIDELITY COVINGTON TRUST	0.02%	29,479 NS	July 31, 2026	N-PORT
VHT · VANGUARD WORLD FUND	0.02%	186,845 SH	Aug. 19, 2026	Daily
WSML · iShares Trust	0.02%	4,261 SH	Sept. 11, 2026	Daily
TILT · FlexShares Trust	0.01%	8,908 NS	July 31, 2026	N-PORT
DFAC · Dimensional ETF Trust	0.01%	181,202 NS	July 31, 2026	N-PORT
DCOR · Dimensional ETF Trust	0.01%	7,762 NS	July 31, 2026	N-PORT
DFAU · Dimensional ETF Trust	0.00%	21,135 NS	July 31, 2026	N-PORT
ITOT · iShares Trust	0.00%	136,268 SH	Sept. 11, 2026	Daily
IWV · iShares Trust	0.00%	27,695 SH	Sept. 11, 2026	Daily
DFSU · Dimensional ETF Trust	0.00%	3,425 NS	July 31, 2026	N-PORT
DFUS · Dimensional ETF Trust	0.00%	16,122 NS	July 31, 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0.00%	3,275,161 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.00%	7,909 SH	Aug. 19, 2026	Daily
IWN · iShares Trust	·	210,645 SH	Sept. 11, 2026	Daily
ISCB · iShares Trust	·	3,438 SH	Sept. 11, 2026	Daily
ISCV · iShares Trust	·	10,240 SH	Sept. 11, 2026	Daily
SMLF · iShares Trust	·	88,041 SH	Sept. 11, 2026	Daily

NRIX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 21 analysts BUY

Median target $34.00 +47.9%

7 33.3% Strong Buy

12 57.1% Buy

2 9.5% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

14 analysts · 2026-09-29

Mean target $33.93 +47.6%

← Below all targets Current price $22.99

Low$25.00 Mean$33.93 High$45.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
NRIX	$1.80B	-5.8	53.9%	-314.9%	-53.6%	·
PURR	$1.58B	2.5	·	3229.8%	24.8%	·
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	·
IRON	$3.01B	-13.2	·	·	-31.3%	·
CLDX	$1.81B	-7.0	-78.0%	-16748.0%	-43.8%	·
IMNM	$2.43B	-8.8	-23.2%	-3060.0%	-47.0%	·
SLS	$577M	-15.1	·	·	-55.4%	·
VRDN	$3.17B	-7.7	23359.9%	-483.6%	-55.4%	·
RXRX	$2.16B	-2.8	26.9%	-863.4%	-62.9%	·

Latest News Recent headlines mentioning this company

23

Roche And Nurix Ink $2.3 Bln Collaboration To Co-Develop BTK Degrader Bexobrutideg Nasdaq · 3 months, 3 weeks ago Nurix Therapeutics Posts Wider Loss In Q1 Nasdaq · 5 months, 3 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

NRIX Nurix Therapeutics, Inc. - Common stock